rs2270694

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003672.4(CDC14A):​c.990G>A​(p.Ser330Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 1,562,224 control chromosomes in the GnomAD database, including 12,304 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1129 hom., cov: 32)
Exomes 𝑓: 0.12 ( 11175 hom. )

Consequence

CDC14A
NM_003672.4 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.23

Publications

11 publications found
Variant links:
Genes affected
CDC14A (HGNC:1718): (cell division cycle 14A) The protein encoded by this gene is a member of the dual specificity protein tyrosine phosphatase family. It is highly similar to Saccharomyces cerevisiae Cdc14, a protein tyrosine phosphatase involved in the exit of cell mitosis and initiation of DNA replication, suggesting a role in cell cycle control. This protein has been shown to interact with, and dephosphorylate tumor suppressor protein p53, and is thought to regulate the function of p53. Alternative splicing of this gene results in several transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
CDC14A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic deafness 105
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal recessive nonsyndromic hearing loss 32
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, PanelApp Australia
  • hearing impairment and infertile male syndrome
    Inheritance: AR Classification: STRONG Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 1-100484304-G-A is Benign according to our data. Variant chr1-100484304-G-A is described in ClinVar as Benign. ClinVar VariationId is 508568.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.23 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.13 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDC14ANM_003672.4 linkc.990G>A p.Ser330Ser synonymous_variant Exon 11 of 16 ENST00000336454.5 NP_003663.2 Q9UNH5-1Q59EF4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDC14AENST00000336454.5 linkc.990G>A p.Ser330Ser synonymous_variant Exon 11 of 16 1 NM_003672.4 ENSP00000336739.3 Q9UNH5-1

Frequencies

GnomAD3 genomes
AF:
0.112
AC:
16967
AN:
151888
Hom.:
1128
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0596
Gnomad AMI
AF:
0.185
Gnomad AMR
AF:
0.117
Gnomad ASJ
AF:
0.209
Gnomad EAS
AF:
0.0618
Gnomad SAS
AF:
0.0936
Gnomad FIN
AF:
0.169
Gnomad MID
AF:
0.133
Gnomad NFE
AF:
0.132
Gnomad OTH
AF:
0.122
GnomAD2 exomes
AF:
0.117
AC:
24079
AN:
205850
AF XY:
0.119
show subpopulations
Gnomad AFR exome
AF:
0.0572
Gnomad AMR exome
AF:
0.0868
Gnomad ASJ exome
AF:
0.214
Gnomad EAS exome
AF:
0.0624
Gnomad FIN exome
AF:
0.168
Gnomad NFE exome
AF:
0.130
Gnomad OTH exome
AF:
0.118
GnomAD4 exome
AF:
0.122
AC:
172533
AN:
1410220
Hom.:
11175
Cov.:
28
AF XY:
0.122
AC XY:
85737
AN XY:
701140
show subpopulations
African (AFR)
AF:
0.0575
AC:
1756
AN:
30528
American (AMR)
AF:
0.0898
AC:
3140
AN:
34984
Ashkenazi Jewish (ASJ)
AF:
0.207
AC:
5033
AN:
24294
East Asian (EAS)
AF:
0.0617
AC:
2340
AN:
37904
South Asian (SAS)
AF:
0.0896
AC:
7005
AN:
78196
European-Finnish (FIN)
AF:
0.159
AC:
8279
AN:
52028
Middle Eastern (MID)
AF:
0.130
AC:
726
AN:
5564
European-Non Finnish (NFE)
AF:
0.126
AC:
137205
AN:
1088658
Other (OTH)
AF:
0.121
AC:
7049
AN:
58064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
6006
12011
18017
24022
30028
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4944
9888
14832
19776
24720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.112
AC:
16972
AN:
152004
Hom.:
1129
Cov.:
32
AF XY:
0.113
AC XY:
8396
AN XY:
74280
show subpopulations
African (AFR)
AF:
0.0596
AC:
2472
AN:
41492
American (AMR)
AF:
0.117
AC:
1782
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.209
AC:
725
AN:
3472
East Asian (EAS)
AF:
0.0618
AC:
320
AN:
5178
South Asian (SAS)
AF:
0.0937
AC:
452
AN:
4824
European-Finnish (FIN)
AF:
0.169
AC:
1778
AN:
10530
Middle Eastern (MID)
AF:
0.136
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
0.132
AC:
8982
AN:
67938
Other (OTH)
AF:
0.120
AC:
252
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
756
1512
2267
3023
3779
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
194
388
582
776
970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.127
Hom.:
2835
Bravo
AF:
0.106
Asia WGS
AF:
0.0700
AC:
242
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Aug 23, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ser330Ser in exon 11 of CDC14A: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 21.12% (1071/5072) of Finnish chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; dbSNP rs2270694). -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.68
DANN
Benign
0.84
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2270694; hg19: chr1-100949860; COSMIC: COSV107404599; API